MN SF61

Amends Minnesota Statutes 256B.0625, subdivision 13e to modify reimbursement provisions for direct injectable drugs used to treat substance use disorder or mental illness under the medical assistance program.

Allows payment for injectable drugs to be made to the administering facility, practitioner, administering pharmacy or pharmacist, or directly to the dispensing pharmacy, rather than exclusively to the administering facility.

Permits dispensing pharmacies to submit claims when they dispense drugs pursuant to a prescription and deliver the filled prescription to the practitioner for subsequent administration, with the commissioner ensuring claims are not duplicated.

Prohibits pharmacies from dispensing practitioner-administered injectable drugs directly to enrollees.

Establishes that ingredient cost reimbursement must be increased by 1.8 percent for prescription and nonprescription drugs subject to the wholesale drug distributor tax under section 295.52.